Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives
The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care. A survey questionnaire was developed to explore the experiences and opinions about EOL...
Saved in:
| Published in | Cancer research and treatment Vol. 50; no. 2; pp. 614 - 623 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
Korean Cancer Association
01.04.2018
대한암학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1598-2998 2005-9256 2005-9256 |
| DOI | 10.4143/crt.2016.446 |
Cover
| Abstract | The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care.
A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses.
A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion.
This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required. |
|---|---|
| AbstractList | The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care.PURPOSEThe aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care.A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses.MATERIALS AND METHODSA survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses.A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion.RESULTSA total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion.This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required.CONCLUSIONThis study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required. Purpose The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care. Materials and Methods A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses. Results A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of “terminal state,” and most respondents tried to disclose the patient’s condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussion was considered when metastasis or disease recurrence occurred or when withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion. Conclusion This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required. KCI Citation Count: 0 The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care. A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses. A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion. This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required. |
| Author | Chang, Hye Jung Kim, Shinmi Kim, JinShil Koh, Su-Jin Baek, Sun Kyung Keam, Bhumsuk Lee, Kyung Hee Kim, Jee Hyun Heo, Dae Seog Kim, Bong-Seog |
| Author_xml | – sequence: 1 givenname: Su-Jin surname: Koh fullname: Koh, Su-Jin – sequence: 2 givenname: Shinmi surname: Kim fullname: Kim, Shinmi – sequence: 3 givenname: JinShil surname: Kim fullname: Kim, JinShil – sequence: 4 givenname: Bhumsuk surname: Keam fullname: Keam, Bhumsuk – sequence: 5 givenname: Dae Seog surname: Heo fullname: Heo, Dae Seog – sequence: 6 givenname: Kyung Hee surname: Lee fullname: Lee, Kyung Hee – sequence: 7 givenname: Bong-Seog surname: Kim fullname: Kim, Bong-Seog – sequence: 8 givenname: Jee Hyun surname: Kim fullname: Kim, Jee Hyun – sequence: 9 givenname: Hye Jung surname: Chang fullname: Chang, Hye Jung – sequence: 10 givenname: Sun Kyung surname: Baek fullname: Baek, Sun Kyung |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28675025$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002335623$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp9kc1v1DAQxS1URLeFG2eUGyCRxXYcx-GAVJUtVFppq1U5W8aZtKZZO3icwv73eLvlU4LTHOY38-a9OSIHPngg5Cmjc8FE9drGNOeUybkQ8gGZcUrrsuW1PCAzVreq5G2rDskR4mdKpaga9ogcciWbmvJ6RnDxbYTowFvAwviuWI3Ou-CxWMNgEnRFCsXCd2Xoy6XroXjn0E6IGXlTnMWwKVbehiFcOUz4_G7DGtB14FNxcb1FZ53xuXEBEUewyd0CPiYPezMgPLmvx-Tj2eLy9EO5XL0_Pz1ZllYokcp8ay1tpZqGGgGtgL7hnZS9BcFUNsXAis5mqgEOnEnBqWwsFx0DaVvg1TF5ud_rY69vrNPBuLt6FfRN1Cfry3NdsZpRqTJb7tnJj2b71QyDHqPbmLjVjOpd0DoHrXdB6xx05t_u-XH6tIHOZr_R_JrZKf3Z8e46697qumWcid1xL-4XxPBlAkx6k5OFYTAewoSataxWiucIMvrsd62fIj--mAG-B2wMiBF6bV0yKf8oS7vhXw5e_TX0X8PfAf3Zv6E |
| CitedBy_id | crossref_primary_10_1016_j_ijnss_2024_03_010 crossref_primary_10_1186_s12904_021_00759_6 crossref_primary_10_4143_crt_2020_735 crossref_primary_10_21215_kjfp_2021_11_5_331 crossref_primary_10_4143_crt_2019_740 crossref_primary_10_1089_pmr_2022_0008 crossref_primary_10_1089_jpm_2019_0402 crossref_primary_10_1186_s12910_024_01088_y crossref_primary_10_1016_j_ijnurstu_2019_03_020 crossref_primary_10_1186_s12904_020_00652_8 crossref_primary_10_1177_26323524231212510 crossref_primary_10_1186_s12910_023_00897_x crossref_primary_10_1007_s00520_020_05750_0 crossref_primary_10_1093_qjmed_hcad246 crossref_primary_10_1016_j_jamda_2020_12_018 crossref_primary_10_1016_j_pec_2018_08_016 crossref_primary_10_1093_jjco_hyaa131 crossref_primary_10_1177_10499091211061713 crossref_primary_10_1016_j_jpainsymman_2018_12_332 crossref_primary_10_1177_0825859718777361 crossref_primary_10_3947_ic_2019_51_2_89 |
| Cites_doi | 10.3399/bjgp10X544032 10.4082/kjfm.2014.35.6.283 10.1146/annurev.clinpsy.1.102803.144118 10.3399/bjgp13X673667 10.1080/15265161003599691 10.1016/S0749-3797(99)00097-5 10.1007/s00520-012-1689-z 10.1111/jgs.12894 10.1200/JCO.2016.70.1474 10.1097/PPO.0b013e3182a76b9c 10.1017/S1478951515000590 10.4143/crt.2015.124 10.1097/NJH.0000000000000034 10.1177/0272989X13501883 |
| ContentType | Journal Article |
| Copyright | Copyright © 2018 by the Korean Cancer Association 2018 |
| Copyright_xml | – notice: Copyright © 2018 by the Korean Cancer Association 2018 |
| DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY ACYCR |
| DOI | 10.4143/crt.2016.446 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2005-9256 |
| EndPage | 623 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_3151068 10.4143/crt.2016.446 PMC5912142 28675025 10_4143_crt_2016_446 |
| Genre | Journal Article |
| GroupedDBID | --- 29B 5-W 53G 8JR 9ZL AAYXX ABDBF ACUHS ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EBD EF. F5P HYE OK1 RPM TR2 C1A M~E NPM 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c484t-43756c38770a4e94ef72d66fce4189981ec4dc4377e2e21642067c24d1e6c9e23 |
| IEDL.DBID | UNPAY |
| ISSN | 1598-2998 2005-9256 |
| IngestDate | Sun Mar 09 07:55:05 EDT 2025 Wed Oct 29 12:03:00 EDT 2025 Thu Aug 21 17:31:00 EDT 2025 Thu Oct 02 10:35:38 EDT 2025 Wed Feb 19 02:43:19 EST 2025 Thu Apr 24 23:06:40 EDT 2025 Tue Jul 01 03:18:47 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Oncologists Advance care planning Resident physician Communication |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c484t-43756c38770a4e94ef72d66fce4189981ec4dc4377e2e21642067c24d1e6c9e23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=http://www.e-crt.org/upload/pdf/crt-2016-446.pdf |
| PMID | 28675025 |
| PQID | 1915882756 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_3151068 unpaywall_primary_10_4143_crt_2016_446 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5912142 proquest_miscellaneous_1915882756 pubmed_primary_28675025 crossref_citationtrail_10_4143_crt_2016_446 crossref_primary_10_4143_crt_2016_446 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-04-01 |
| PublicationDateYYYYMMDD | 2018-04-01 |
| PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Cancer research and treatment |
| PublicationTitleAlternate | Cancer Res Treat |
| PublicationYear | 2018 |
| Publisher | Korean Cancer Association 대한암학회 |
| Publisher_xml | – name: Korean Cancer Association – name: 대한암학회 |
| References | ref13 ref12 ref15 ref14 ref11 (ref1) 2008 ref2 Berlinger (ref18) 2013 ref17 ref16 Rogne (ref3) 2014 (ref4) 2014 Ryan (ref23) 2014 Ngo-Metzger (ref19) 2008 ref22 ref21 (ref10) 2016 Institute of (ref25) 2015 Meisel (ref24) 2008 (ref20) 2016 (ref8) 2015 ref7 ref9 ref6 ref5 |
| References_xml | – ident: ref22 doi: 10.3399/bjgp10X544032 – start-page: 45 year: 2014 ident: ref23 – ident: ref21 doi: 10.4082/kjfm.2014.35.6.283 – volume-title: Korea Law Information Center [Internet] year: 2016 ident: ref10 – ident: ref2 doi: 10.1146/annurev.clinpsy.1.102803.144118 – ident: ref11 doi: 10.3399/bjgp13X673667 – ident: ref5 doi: 10.1080/15265161003599691 – year: 2016 ident: ref20 – year: 2014 ident: ref4 – ident: ref14 doi: 10.1016/S0749-3797(99)00097-5 – ident: ref13 doi: 10.1007/s00520-012-1689-z – year: 2015 ident: ref25 – start-page: 1 year: 2014 ident: ref3 – ident: ref6 doi: 10.1111/jgs.12894 – ident: ref16 doi: 10.1200/JCO.2016.70.1474 – start-page: 51 year: 2008 ident: ref24 – volume-title: Chapter 9. Coverage of hospice services under hospital insurance (Rev.209.) [Internet] year: 2015 ident: ref8 – year: 2013 ident: ref18 – ident: ref15 doi: 10.1097/PPO.0b013e3182a76b9c – start-page: 167 volume-title: End-of-Life care: guidelines for patient-centered communication year: 2008 ident: ref19 – year: 2008 ident: ref1 – ident: ref9 doi: 10.1017/S1478951515000590 – ident: ref12 doi: 10.4143/crt.2015.124 – ident: ref17 doi: 10.1097/NJH.0000000000000034 – ident: ref7 doi: 10.1177/0272989X13501883 |
| SSID | ssj0064371 |
| Score | 2.2470746 |
| Snippet | The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL... Purpose The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on... |
| SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 614 |
| SubjectTerms | Original 의약학 |
| Title | Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28675025 https://www.proquest.com/docview/1915882756 https://pubmed.ncbi.nlm.nih.gov/PMC5912142 http://www.e-crt.org/upload/pdf/crt-2016-446.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002335623 |
| UnpaywallVersion | publishedVersion |
| Volume | 50 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Cancer Research and Treatment, 2018, 50(2), , pp.614-623 |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: ABDBF dateStart: 20120301 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: DIK dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: 5-W dateStart: 20010101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: RPM dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb5swFD5qE2nby-4Xdqm8aZeHihSIMbC3dG3UTWubTYvUPVlgmxYlM4iLpu3X7xhC2qrb1CcQPgJhf5a_D46_A_DaVbEvoljZSI4DFCgptUPpCFuINHAUcuC4dbw5PGIHc_rpxD_ZgL4IYptVaYuy22zQFMs8ljuFTHfwEg6oy2yULyO8sAlD5iP7HsBwfjSbfG9tUSOzoaAtf9sabEa4nHe57hRZgbmFSeViI2rY7oVVaFOX6d8I5tU8yZuNLuJfP-Pl8sIiNL0DX_qtPF3uyWLU1MlI_L7q7Hjt97sLt1eMlEw6CN2DDaXvw43D1T_3B1CduyFXJNaSHBeZNmAlbSKdkqTOyb6Wdp7an7NUkb2sEo1JrtXvybTMf5Bj3VpjI6Cqd-0dvipTJFTXZNZ_V8GG2fm2z-ohzKf73z4c2KtSDbagIa1tOg58JsZhEDgxVRFVaeBJxlKhqGsUnasElQKjAuUhAlD0IDSER6WrmIiUN34EA51r9QRIYMwkA-F7IkyoI72IKTcJFdIen3qJTCzY7oeOi5WPuSmnseSoZ8xAc-xLbvqSY19a8GYdXXT-Hf-Ie4Uo4AuRcWO4bY6nOV-UHGXFRz5GXuSw0IKXPUg4zkLzayXWKm8qjqrXR62CnWDB4w4068d5IYoypJYWBJfgtA4wD7zcorOz1unbj1xjiWfB2zXw_vsWT68b-Axu4WnYpSA9h0FdNuoFsqs62YLhZHdvd7q1mlh_AJNhJF8 |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ZbtQwFL1qpxLwwr6ETQaxPKBMk4xjJ7xV0FFBtB0QI7VPVmI7bTSDE2URgq_nOplMWxVQnxLFV4liH8vnJNfnArzydRLKONEukmOOAiWjbqQ86UqZcU8jB046x5v9A7Y3p5-PwqMNGIogdlmVrqz6zQZtuSwStV2qbBsv4YD6zEX5MsYLm7DFQmTfI9iaH8x2jjtb1NhuKOjK33YGmzEu532uO0VWYG9hU7nYmFq2e24V2jRV9jeCeTlP8npryuTXz2S5PLcITW_B12ErT597shi3TTqWvy87O175_W7DzRUjJTs9hO7AhjZ34dr-6p_7PajP3JBrkhhFDsvcWLCSLpFOK9IUZNcot8jcL3mmyce8lq1NrjXvybQqfpBD01ljI6Dqt90dvmlbJNQ0ZDZ8V8GG2dm2z_o-zKe73z_suatSDa6kEW1cOuEhk5OIcy-hOqY644FiLJOa-lbR-VpSJTGK6wARgKIHoSEDqnzNZKyDyQMYmcLoR0C4NZPkMgxklFJPBTHTfhpppD0hDVKVOvBuGDohVz7mtpzGUqCesQMtsC-F7UuBfenA63V02ft3_CPuJaJALGQurOG2PZ4UYlEJlBWfxAR5kcciB14MIBE4C-2vlcTooq0Fqt4QtQp2ggMPe9CsHxdEKMqQWjrAL8BpHWAfeLHF5Ked03cY-9YSz4E3a-D99y0eXzXwCdzA06hPQXoKo6Zq9TNkV036fDWh_gB46SLt |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Experiences+and+Opinions+Related+to+End-of-Life+Discussion%3A+From+Oncologists%27+and+Resident+Physicians%27+Perspectives&rft.jtitle=Cancer+research+and+treatment&rft.au=Koh%2C+Su-Jin&rft.au=Kim%2C+Shinmi&rft.au=Kim%2C+JinShil&rft.au=Keam%2C+Bhumsuk&rft.date=2018-04-01&rft.issn=2005-9256&rft.eissn=2005-9256&rft.volume=50&rft.issue=2&rft.spage=614&rft_id=info:doi/10.4143%2Fcrt.2016.446&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon |